M3 Wake Research - Charleston

Clinical research site in Charleston, South Carolina

Part of M3 Wake Research

As of July 2026, 2 paid clinical trials are recruiting at M3 Wake Research - Charleston in Charleston, South Carolina. Active studies at this site cover conditions such as Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) and Diabetic Peripheral Neuropathic Pain. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at M3 Wake Research - Charleston (2)

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

for Elevated Lp(a)

127 locations incl. Gilbert

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

for Diabetic Peripheral Neuropathic Pain

59 locations incl. Anniston

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All·Age: 18 - 80

Code: NCT06628908·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

More research sites in Charleston

Medical University of South Carolina (383 trials)
Medical University of South Carolina (MUSC) (29 trials)
Ralph H. Johnson VA Medical Center, Charleston, SC (22 trials)
Ralph H Johnson VA Medical Center (11 trials)
MUSC (7 trials)
Hollings Cancer Center (6 trials)
MUSC Hollings Cancer Center (6 trials)
Ralph H. Johnson VA Health Care System (6 trials)
Medical University of South Carolina Hollings Cancer Center (5 trials)
GSK Investigational Site (4 trials)

Explore more

Paid clinical trials in Charleston, SC · South Carolina clinical trials